#USA #New York #Class Action #Gross Law Firm #Sana Biotechnology

Important Notice for Shareholders of Sana Biotechnology, Inc.

As of April 3, 2025, shareholders of Sana Biotechnology, Inc. (NASDAQ: SANA) should be aware of a critical announcement from The Gross Law Firm. This firm is urging all shareholders who acquired shares within a specified range to reach out to them before May 20, 2025, to discuss their legal rights and options regarding a potential class action lawsuit.

Details of the Allegations

The legal complaint details several critical allegations against Sana Biotechnology. It is being claimed that during the defined class period from March 17, 2023, to November 4, 2024, the company made materially misleading statements and failed to disclose essential information. Among these allegations are:

1. Financial Risk: The company was reportedly facing considerable financial strains that could hinder its operations and the progression of key product candidates.
2. Misleading Product Potential: Products like SC291 (in oncology), SC379, and SG299 were alleged to be less promising than the representations made by the defendants.
3. Funding Concerns: To conserve cash and prioritize more viable product lines, Sana Biotechnology may reduce funding for certain candidates or even cut jobs significantly.
4. Overstated Financial Health: The allegations suggest that the public statements made by the company painted an overly rosy picture of its financial health, misleading investors about its capacity to operate and advance product development.

This series of misrepresentations raises serious concerns for current shareholders who are advised to act swiftly.

Key Dates and Deadlines

Shareholders wishing to register for participation in the potential recovery process within this class action lawsuit must do so by May 20, 2025. It is imperative to not delay in safeguarding your rights and interests.

If you are eligible and want to ensure you receive updates regarding the lawsuit's progress, it is recommended to complete the registration at the following link: Client Registration.

Next Steps for Interested Shareholders

Upon registration, shareholders will receive access to a portfolio monitoring service, keeping them informed throughout the case's developments. Importantly, there is no cost or obligation associated with joining this class action. In addition, it is worth noting that being appointed as a lead plaintiff is not a prerequisite for participating in any potential recovery.

Choosing The Gross Law Firm

The Gross Law Firm is nationally recognized for its commitment to protecting investors' rights. Their mission focuses on addressing cases of deceit or fraud in the corporate sector, ensuring companies uphold accountability for their actions. If you feel you have been wronged due to misleading statements by Sana Biotechnology, this may be a significant opportunity for you to seek justice and recover your lost investments.

Contact Information

For more details or personal inquiries, shareholders should reach out to:

The Gross Law Firm
15 West 38th Street, 12th Floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

This notice serves as an essential call-to-action for all grieving shareholders of Sana Biotechnology. Ensure your voice is heard by contacting The Gross Law Firm before the deadline to avoid missing this opportunity for potential recovery.